Bioxcel Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.50

+0.13 (+9.49%)

As of Feb 8, 2:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 1 9%

Sell 1 9%

Price Target

Analyst Price Target +1,364.0% upside

Low Target $14.05

Average Target $21.96

High Target $26.87

Current Price $1.50

Current
$1.50

Target
$21.96

$14.05 $21.96 avg $26.87

Scenario Analysis

Bear Case

$14.05

836.7%

Low target

Base Case

$21.96

+1,364.0%

Avg target

Bull Case

$26.87

+1,691.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$24.11

-93.8% from high

52-Week Low

$14.44

+-89.6% from low

Target vs 52W High

$21.96

-8.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%